ArticleThe archives of bone and joint surgery2025
Tissue Engineering Technologies in the Management of Bone Infections.
Article in The archives of bone and joint surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteomyelitis is a calamitous illness produced by microbial infection in deep osseous tissue. Its elevated recurrence percentage is a major defiance in management. Besides, microbial-mediated dysregulation of the osseous tissue immune microhabitat hinders the process of osseous regeneration, resulting in defective repair of the osseous defect. In spite of advancements in surgical approaches and medication employments for the management of infections of the osseous tissue within the most recent years, dares endure in clinical treatment. The creation and employment of tissue engineering materials have rendered new approaches for the management of infections of the osseous tissue. In the discipline of tissue engineering, we should center on utilizing materials science and engineering technology to create biomimetic 3D printed degradable frameworks with structure, layout, and mechanical attributes; accomplishing controlled liberation of antimicrobial medications via nanocarriers or scaffold surface coating technologies; and utilizing coaxial printing or gradient printing techniques to accomplish graded controlled liberation of antimicrobial medications and osteogenic active drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.